Aditxt Valuation
| ADTX Stock | USD 4.84 0.61 11.19% |
At this time, the firm appears to be undervalued. Aditxt Inc shows a prevailing Real Value of $18.83 per share. The current price of the firm is $4.84. Our model approximates the value of Aditxt Inc from analyzing the firm fundamentals such as Current Valuation of 7.85 M, shares owned by institutions of 0.09 %, and Return On Equity of -2.82 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Aditxt's price fluctuation is slightly risky at this time. Calculation of the real value of Aditxt Inc is based on 3 months time horizon. Increasing Aditxt's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Aditxt is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aditxt Stock. However, Aditxt's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.84 | Real 18.83 | Hype 6.6 |
The intrinsic value of Aditxt's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aditxt's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aditxt Inc helps investors to forecast how Aditxt stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aditxt more accurately as focusing exclusively on Aditxt's fundamentals will not take into account other important factors: Aditxt Total Value Analysis
Aditxt Inc is presently anticipated to have valuation of 7.85 M with market capitalization of 2.73 M, debt of 6.92 M, and cash on hands of 803.97 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Aditxt fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.85 M | 2.73 M | 6.92 M | 803.97 K |
Aditxt Investor Information
The company has price-to-book (P/B) ratio of 0.21. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aditxt Inc recorded a loss per share of 994.14. The entity had not issued any dividends in recent years. The firm had 1:113 split on the 3rd of November 2025. Based on the key indicators related to Aditxt's liquidity, profitability, solvency, and operating efficiency, Aditxt Inc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Aditxt Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aditxt has an asset utilization ratio of 0.42 percent. This suggests that the Company is making $0.004168 for each dollar of assets. An increasing asset utilization means that Aditxt Inc is more efficient with each dollar of assets it utilizes for everyday operations.Aditxt Ownership Allocation
Almost 99.91 percent of Aditxt outstanding shares are held by general public with 0.09 % by other corporate entities.Aditxt Profitability Analysis
The company reported the previous year's revenue of 133.99 K. Net Loss for the year was (34.45 M) with loss before overhead, payroll, taxes, and interest of (528.23 K).About Aditxt Valuation
Our relative valuation model uses a comparative analysis of Aditxt. We calculate exposure to Aditxt's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aditxt's related companies.Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia. Aditxt operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 58 people.
Aditxt Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 13.2 K | |
| Forward Price Earnings | 0.3707 |
Additional Tools for Aditxt Stock Analysis
When running Aditxt's price analysis, check to measure Aditxt's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aditxt is operating at the current time. Most of Aditxt's value examination focuses on studying past and present price action to predict the probability of Aditxt's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aditxt's price. Additionally, you may evaluate how the addition of Aditxt to your portfolios can decrease your overall portfolio volatility.